Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$148.35
▼ $1.19 (−0.80%) today
Markets closed · 6:58pm ET

MRK Coverage

Page 69
6:23am ET
Investing

Merck (MRK): All Bad News

Merck released earnings, and cut its forecasts. No wonder. Its Q1 numbers were atrocious. Revenue  for the first quarter of 2009 was $5.4 billion, a decrease of 8%compared to the first quarter of…

MRK
Douglas A. McIntyre
1:52pm ET
Investing

S&P 500 Pushes Toward 25% Gain Since March 9th

At 842, the S&P is pushing near a 25% gains since it bottomed for the year-to-date at 677 on March 9th. The bank stocks continue an extraordinary run over that period. Citigroup…

Douglas A. McIntyre
5:25am ET
Health and Healthcare

Merck’s (MRK) New Merger, Another Way To Save Money

Merck (MRK) is merging with Schering-Plough (SGP) in a deal that the companies say is worth $41.1  billion. In reality, Merck is making an acquisition. Its shares will be the currency to…

MRK
Douglas A. McIntyre
8:57am ET
Health and Healthcare

Merck Bares All In Pipeline Presentation (MRK)

Merck & Co., Inc. (NYSE: MRK) today outlined its drug pipeline and has reaffirmed its guidance given last week.  Merck plans to emerge next year and into the next decade leaner and…

MRK
Douglas A. McIntyre
9:06am ET
Jobs

DJIA Losing 3 Trifecta (T, DD, MRK)

It is easy to get pumped up about overseas rate cuts, but there is cautionary data from at least three DJIA components.  Wal-Mart is the economic trade-down so that win in retail…

DD MRK T
Douglas A. McIntyre
7:29am ET
Health and Healthcare

Merck (MRK): People Won’t Even Buy Drugs

So much fore feeling better in a bad economy. Merck (MRK) offered lackluster guidance for next year and the stock is off before the open. According to Reuters, "Merck said it expected…

MRK
Douglas A. McIntyre